Action 300357 ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Actions

300357

CNE100001R58

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
23,69 CNY +1,46 % Graphique intraday de Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. +7,19 % -18,31 %
18/04 Zhejiang Wolwo Bio-Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
2023 Zhejiang Wolwo Bio-Pharmaceutical Co. publie ses résultats pour la période de neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023
Shanghai Wolwo Stem Cell Technology Co., Ltd. announced that it has received CNY 400 million in funding from Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shanghai Wolwo Stem Cell Technology Co., Ltd. announced that it expects to receive CNY 400 million in funding from Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. and other investors
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves Executive Appointments
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Implements Final Profit Distribution Plan A shares for 2021, Payable on June 16, 2022
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2021
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Announces Final Cash Dividend for 2020, Payable on 01 June 2021
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300357
  4. Actualités Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
  5. Autres langues